Whitney L. Hensing, MD

Whitney Hensing, MD, is a fellowship-trained and board-certified hematology oncologist. Dr. Hensing develops a personalized plan to fit each patient’s specific breast cancer, medical history, and treatment goals. 
During her fellowship at Washington University and Siteman Cancer Center, Dr. Hensing developed a multicenter phase 1 clinical trial using a unique drug combination in patients with HER2 altered tumors. She was awarded the Young Investigator Award in breast cancer disparities research from the ASCO Conquer Cancer Foundation. 
Dr. Hensing’s clinical interests include clinical trials and developing new targeted therapies for patients with breast cancer. 
 

Book Chapters
Whitney Hensing and Lindsay Peterson. “Chapter 43: Cancer Survivorship.” The Washington Manual of Oncology 4th edition, edited by Daniel Morgensztern, Armin Ghobadi and Ramaswamy Govindan, Wolters Kluwer, November 2020, pages 1147-1164.  

Peer-reviewed publications
Ademuyiwa FO, Slayer P, Tao Y, Luo J, Hensing WL, Afolalu A, Peterson L, Weilbaecher K, Houston W, Baumann A, Desai M, Jones S, Linnenbringer E, Bierut L. Genetic counseling and testing in African American patients with breast cancer: A Nationwide Survey of US Oncologists. Journal of Clinical Oncology [submitted]
Hensing WL, Poplack SP, Herman CR, Sutcliffe S, Colditz GA, Ademuyiwa FO. Racial differences in no-show rates for screening mammography. Cancer. 2021 Apr 1. Epub ahead of print.  
Hensing WL, Santa-Maria CA, Peterson LL, Sheng JY. Landmark trials in the medical oncology management of early-stage breast cancer. Semin Oncol. 2020 Oct;47(5):278-292. 
Fabian CJ, Kimler BF, Phillips TA, Box JA, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Premenopausal Women. Cancer Prevention Research. 2015 Oct;8(10):912-21. 
Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, Hursting SD. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women. Cancer Prevention Research. 2015 Oct;8(10):922-31.
Elsarraj HS, Hong Y, Valdez KE, Michaels W, Hook M, Smith WP, Chien J, Herschkowitz JI, Troester MA, Beck M, Inciardi M, Gatewood J, May L, Cusick T, McGinness M, Ricci L, Fan F, Tawfik O, Marks JR, Knapp JR, Yeh HW, Thomas P, Carrasco DR, Fields TA, Godwin AK, Behbod F. Expression profiling of in vivo ductal carcinoma in situ progression models identified B cell lymphoma-9 as a molecular driver of breast cancer invasion. Breast Cancer Research. 2015 Sep 17;17:128.